1.
Schlesinger T, Lebwohl M, Del Rosso J, Patel VA, Kircik L, Armstrong A, Berman B, Rigel D, Narayanan S, Koscielny V, Kasujee I, Bhatia N. Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study). J of Skin [Internet]. 2023Nov.13 [cited 2024Sep.20];7(6):s263. Available from: https://dermsquared.com/skin/article/view/2338